Rachel Lane PhD
Chief Business Officer
United States
62 investmentsRachel Lane PhD is a Chief Business Officer based in United States. Rachel Lane PhD has backed 62 companies, including Black Diamond Therapeutics, Kyras Therapeutics and CRISPR Therapeutics. Investment focus areas include Health Care, Genetics and Women Founded.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (62)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Black Diamond Therapeutics | — | — | — | — |
| 2 | Kyras Therapeutics | — | — | — | — |
| 3 | CRISPR Therapeutics | — | — | — | — |
| 4 | Aligos Therapeutics | — | — | — | — |
| 5 | Aprea | — | — | — | — |
| 6 | CODA Biotherapeutics | — | — | — | — |
| 7 | Therachon | — | — | — | — |
| 8 | Inception IBD | — | — | — | — |
| 9 | Monteris Medical | — | — | — | — |
| 10 | Zyga Technology | — | — | — | — |
| 11 | Inari Medical | — | — | — | — |
| 12 | Century Therapeutics | — | — | — | — |
Showing 1–12 of 62
Page 1 of 6
Access Full Contact Information
Get Rachel Lane PhD's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.